GSK plc ADR buy Guggenheim
Start price
04.03.24
/
50%
€38.80
Target price
04.03.25
-
Performance (%)
-7.22%
End price
05.03.25
€36.00
Summary
This prediction ended on 05.03.25 with a price of €36.00. With a performance of -7.22%, the BUY prediction for GSK plc ADR by Guggenheim closed slightly in the red. Dividends of €1.45 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | 3.306% | 3.306% | 66.667% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % |
Comments by Guggenheim for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten